Submit your picks! | @NephMadness | @nephmadness.bsky.social | NephMadness 2026 Selection Committee Member: Sam Kant @kantsmd Sam Kant is an Nephrologist & Transplant Physician at St. Vincent’s…

Quickly and easily listen to Febrile for free!

This week, NephJC will discuss whether obinutuzumab is ready to outperform tacrolimus in primary membranous nephropathy

Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?

Curious how n-3 PUFAs may cut serious cardiovascular events in dialysis? 🐟 A big signal, a big dose, and a big discussion ahead — don’t miss this #NephJC! Check out the VA made by our master Brian Rifkin

Spironolactone is safe and effective in treating hypokalemia in PD patients. It is also an effective antihypertensive agent and merits further study in the PD population.